STOCK TITAN

Incyte to Present at Upcoming Investor Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Incyte (NASDAQ:INCY) will present at the Guggenheim Healthcare Talks Oncology Day on February 8, 2023, at 1:35 p.m. (EST) in New York. This presentation will be available for live webcast and can be accessed via Investor.Incyte.com. A replay of the event will be available for 30 days after the broadcast.

Based in Wilmington, Delaware, Incyte is a global biopharmaceutical company dedicated to addressing serious unmet medical needs through the development and commercialization of proprietary therapeutics. For more insights, visit Incyte.com.

Positive
  • None.
Negative
  • None.

WILMINGTON, Del.--(BUSINESS WIRE)-- Incyte (Nasdaq:INCY) announced today that it will present at the Guggenheim Healthcare Talks l Oncology Day on Wednesday, February 8, 2023 at 1:35 p.m. (EST) in New York.

The presentation will be webcast live and can be accessed at Investor.Incyte.com and will be available for replay for 30 days.

About Incyte

Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit Incyte.com and follow @Incyte.

Incyte

Media

Catalina Loveman

+1 302 498 6171

cloveman@incyte.com

Investors

Christine Chiou

+1 302 274 4773

cchiou@incyte.com

Source: Incyte

FAQ

What event will Incyte present at on February 8, 2023?

Incyte will present at the Guggenheim Healthcare Talks Oncology Day.

What time is Incyte's presentation on February 8, 2023?

The presentation is scheduled for 1:35 p.m. (EST).

Where can I watch Incyte's presentation live?

You can watch the presentation live at Investor.Incyte.com.

How long will the replay of Incyte's presentation be available?

The replay will be available for 30 days after the event.

What is the focus of Incyte as a biopharmaceutical company?

Incyte focuses on finding solutions for serious unmet medical needs.

Incyte Genomics Inc

NASDAQ:INCY

INCY Rankings

INCY Latest News

INCY Stock Data

13.56B
188.30M
2.04%
97.86%
3.85%
Biotechnology
Services-commercial Physical & Biological Research
Link
United States of America
WILMINGTON